Welcome to LookChem.com Sign In|Join Free

CAS

  • or
5α-hydroxy Laxogenin is a brassinosteroid analog and a derivative of diosgenin.Topical administration of 5α-hydroxy laxogenin (4, 8, and 12 ppm), in combination with a commercial fertilizer, increases the yield and fresh weight of endives (C. endivia).It also inhibits sodium chloride-induced decreases in the fresh weight of lettuce shoots and roots when applied topically at concentrations of 0.1 and 1 μM, as well as inhibits increases in ethylene emission at a concentration of 1 μM.

56786-63-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 56786-63-1 Structure
  • Basic information

    1. Product Name: Spirostan-6-one, 3,5-dihydroxy-, (3b,5a,25R)-
    2. Synonyms: Spirostan-6-one, 3,5-dihydroxy-, (3b,5a,25R)-;5a-hydroxy laxogenin;DI 31;Brassinosteroid BB 16;Biobras 16;BB 16;(3beta,5alpha,25R)-3,5-Dihydroxyspirostan-6-one;(2AR,2'R,4S,5'R,6aR,6bS,8aS,8bR,9S,11aS,12aS,12bS)-2a,4-dihydroxy-5',6a,8a,9-tetramethylicosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-2(11aH)-one
    3. CAS NO:56786-63-1
    4. Molecular Formula: C27H42O5
    5. Molecular Weight: 446.619
    6. EINECS: 1312995-182-4
    7. Product Categories: N/A
    8. Mol File: 56786-63-1.mol
  • Chemical Properties

    1. Melting Point: 247-250 °C
    2. Boiling Point: 578.4±50.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: White or off-white powder
    5. Density: 1.21±0.1 g/cm3 (20 oC 760 Torr)
    6. Refractive Index: N/A
    7. Storage Temp.: Sealed in dry,Room Temperature
    8. Solubility: N/A
    9. PKA: 12.62±0.70(Predicted)
    10. CAS DataBase Reference: Spirostan-6-one, 3,5-dihydroxy-, (3b,5a,25R)-(CAS DataBase Reference)
    11. NIST Chemistry Reference: Spirostan-6-one, 3,5-dihydroxy-, (3b,5a,25R)-(56786-63-1)
    12. EPA Substance Registry System: Spirostan-6-one, 3,5-dihydroxy-, (3b,5a,25R)-(56786-63-1)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 56786-63-1(Hazardous Substances Data)

56786-63-1 Usage

Uses

5α-Hydroxy laxogenin is a synthetic derivative of a naturally occurring spirostane-type steroid, laxogenin.?It is a synthetic spirostane-type steroid, which is contained in dietary supplements and advertised as anabolic agent.

Check Digit Verification of cas no

The CAS Registry Mumber 56786-63-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,7,8 and 6 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 56786-63:
(7*5)+(6*6)+(5*7)+(4*8)+(3*6)+(2*6)+(1*3)=171
171 % 10 = 1
So 56786-63-1 is a valid CAS Registry Number.

56786-63-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name Spirostan-?6-?one, 3,?5-?dihydroxy-?, (3β,?5α,?25R)?-

1.2 Other means of identification

Product number -
Other names Spirostan-6-one, 3,5-dihydroxy-, (3b,5a,25R)-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:56786-63-1 SDS

56786-63-1Synthetic route

(25R)-3α,5-cyclo-5α-spirostan-6-one
127128-79-4

(25R)-3α,5-cyclo-5α-spirostan-6-one

(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

Conditions
ConditionsYield
With acetic acid for 2h; Heating;98%
(25R)-3β-acetoxy-5-hydroxy-5α-spirostan-6-one
5874-17-9

(25R)-3β-acetoxy-5-hydroxy-5α-spirostan-6-one

(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

Conditions
ConditionsYield
With sodium hydrogencarbonate In methanol; water for 3h; Reflux;95%
(25R)-spirostan-22α-O-3β,5α,6β-triol
56816-69-4

(25R)-spirostan-22α-O-3β,5α,6β-triol

(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

Conditions
ConditionsYield
With N-Bromosuccinimide In 1,4-dioxane; water at 20℃; for 2h; Darkness;83%
Multi-step reaction with 3 steps
1: 84 percent / imidazole / dimethylformamide / 3 h
2: PCC / CH2Cl2 / 0 - 20 °C
3: 7.14 g / TBFA / tetrahydrofuran / 6 h
View Scheme
C33H56O5Si

C33H56O5Si

(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

Conditions
ConditionsYield
With TBFA In tetrahydrofuran for 6h;7.14 g
(25R)-3β-(t-butyldimethylsilyloxy)-5α-spirostane-5,6β-diol
876908-18-8

(25R)-3β-(t-butyldimethylsilyloxy)-5α-spirostane-5,6β-diol

(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: PCC / CH2Cl2 / 0 - 20 °C
2: 7.14 g / TBFA / tetrahydrofuran / 6 h
View Scheme
5,6-epoxyspirostane

5,6-epoxyspirostane

(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: perchloric acid / water; tetrahydrofuran / 3 h / 20 °C
2: N-Bromosuccinimide / water; 1,4-dioxane / 2 h / 20 °C / Darkness
View Scheme
(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

2,3,4,6-tetra-O-benzoyl-D-glucopyranosyl trichloroacetimidate
149707-75-5

2,3,4,6-tetra-O-benzoyl-D-glucopyranosyl trichloroacetimidate

5α-hydroxylaxogenyl 2,3,4,6-tetra-O-benzoyl-β-D-glucopyranoside
1373440-75-5

5α-hydroxylaxogenyl 2,3,4,6-tetra-O-benzoyl-β-D-glucopyranoside

Conditions
ConditionsYield
With trimethylsilyl trifluoromethanesulfonate In dichloromethane at 20℃; for 1h; Inert atmosphere; Molecular sieve;94%
p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

(25R)-6-oxo-3β-(p-toluenesulfonyloxy)-5α-spirostane

(25R)-6-oxo-3β-(p-toluenesulfonyloxy)-5α-spirostane

Conditions
ConditionsYield
With pyridine at 20℃; for 24h;88%
With pyridine at 20℃; for 24h;
With pyridine at 20℃;
With pyridine
O-carboxymethylhydroxylamine hydrochloride
20295-82-3

O-carboxymethylhydroxylamine hydrochloride

(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

(25R)-6E-[O-(carboxymethyl)oximino]-5-hydroxy-5α-spirostan-3β-ol

(25R)-6E-[O-(carboxymethyl)oximino]-5-hydroxy-5α-spirostan-3β-ol

Conditions
ConditionsYield
With pyridine at 20℃;88%
(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

(25R)-5α-hydroxy-5α-spirosta-3,6-dione
74395-54-3

(25R)-5α-hydroxy-5α-spirosta-3,6-dione

Conditions
ConditionsYield
With Jones reagent In water; acetone at 20℃;81.5%
(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

(25R)-3β,5-dihydroxy-5β-spirostan-6-one
876908-20-2

(25R)-3β,5-dihydroxy-5β-spirostan-6-one

Conditions
ConditionsYield
With potassium hydroxide In methanol for 24h; Heating;74%
phenyl isocyanate
103-71-9

phenyl isocyanate

(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

(25R)-5α-hydroxy-6-oxo-spirostan-3β-yl phenylcarbamate

(25R)-5α-hydroxy-6-oxo-spirostan-3β-yl phenylcarbamate

Conditions
ConditionsYield
With hydrogenchloride In chloroform; water for 24h; Reflux;68%
(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

methyl iodide
74-88-4

methyl iodide

6β-methyl-5α-(25R)-spirostane-3β,5,6α-triol
83110-94-5

6β-methyl-5α-(25R)-spirostane-3β,5,6α-triol

Conditions
ConditionsYield
With magnesium 1.) ether, 2.) THF, 3 h, reflux; Yield given. Multistep reaction;
formic acid
64-18-6

formic acid

(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

C28H42O6

C28H42O6

Conditions
ConditionsYield
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 20℃; for 24h; Mitsunobu reaction;
methanesulfonic acid
75-75-2

methanesulfonic acid

(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

C28H44O7S

C28H44O7S

Conditions
ConditionsYield
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 40℃; for 24h; Mitsunobu reaction;
With dmap; di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 20℃; for 48.25h; Mitsunobu reaction; Inert atmosphere;
acetic anhydride
108-24-7

acetic anhydride

(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

(25R)-3β-acetoxy-5-hydroxy-5α-spirostan-6-one
5874-17-9

(25R)-3β-acetoxy-5-hydroxy-5α-spirostan-6-one

Conditions
ConditionsYield
With pyridine at 20℃;
(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

C27H40O5
325125-66-4

C27H40O5

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: pyridine / 20 °C
2: 2.03 g / Jones reagent / acetone / 2 h / Heating
View Scheme
(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

C27H42O5

C27H42O5

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: pyridine / 20 °C
2: 2.03 g / Jones reagent / acetone / 2 h / Heating
3: H2 / Pd/C / ethanol / 24 h
View Scheme
(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

(25R)-5,6-seco-A-homo-5(10)-oxa-5-oxo-spirostan-6-oic acid
909879-88-5

(25R)-5,6-seco-A-homo-5(10)-oxa-5-oxo-spirostan-6-oic acid

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: pyridine / 20 °C
2: 2.03 g / Jones reagent / acetone / 2 h / Heating
3: H2 / Pd/C / ethanol / 24 h
4: 1.54 g / mCPBA / CH2Cl2 / 20 °C
View Scheme
(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

C47H69N3O12

C47H69N3O12

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: pyridine / 20 °C
2: 2.03 g / Jones reagent / acetone / 2 h / Heating
3: H2 / Pd/C / ethanol / 24 h
4: 1.54 g / mCPBA / CH2Cl2 / 20 °C
5: 1.1 g / methanol / 20 °C
View Scheme
(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

(25R)-5-hydroxy-5α-spirostan-6-one
321857-67-4

(25R)-5-hydroxy-5α-spirostan-6-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 88 percent / pyridine / 24 h / 20 °C
2: 90 percent / LiBr; Li2CO3 / dimethylformamide / 1 h / Heating
View Scheme
Multi-step reaction with 2 steps
1: pyridine / 24 h / 20 °C
2: 2.29 g / LiBr; Li2CO3 / dimethylformamide / 2 h / Heating
View Scheme
(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

(25R)-2α,3α,5-trihydroxy-5α-spirostan-6-one

(25R)-2α,3α,5-trihydroxy-5α-spirostan-6-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 88 percent / pyridine / 24 h / 20 °C
2: 90 percent / LiBr; Li2CO3 / dimethylformamide / 1 h / Heating
3: 91 percent / OsO4 / N-methylmorpholine N-oxide / 2-methyl-propan-2-ol; tetrahydrofuran; H2O / 24 h / 20 °C
View Scheme
(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

(25R)-3β-amino-5-hydroxy-5α-spirostan-6-one

(25R)-3β-amino-5-hydroxy-5α-spirostan-6-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: Ph3P; DIAD / tetrahydrofuran / 24 h / 40 °C
2: 595 mg / NaN3 / various solvent(s) / 48 h / 50 °C
3: H2 / Lindlar catalyst / ethanol / 36 h
View Scheme
(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

(25R)-3β-amino-5-hydroxy-5β-spirostan-6-one

(25R)-3β-amino-5-hydroxy-5β-spirostan-6-one

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: Ph3P; DIAD / tetrahydrofuran / 24 h / 40 °C
2: 595 mg / NaN3 / various solvent(s) / 48 h / 50 °C
3: H2 / Lindlar catalyst / ethanol / 36 h
4: 620 mg / Et3N / dioxane / 20 h
5: KOH / methanol / 24 h / Heating
6: 313 mg / CF3CO2H / CH2Cl2 / 0.17 h
View Scheme
(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

(25R)-2β,3β-epoxy-5-hydroxy-5β-spirostan-6-one
876908-24-6

(25R)-2β,3β-epoxy-5-hydroxy-5β-spirostan-6-one

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 74 percent / KOH / methanol / 24 h / Heating
2: pyridine / 24 h / 20 °C
3: 2.36 g / Li2CO3; LiBr / dimethylformamide / 2 h / Heating
4: 48 percent / mCPBA / CH2Cl2 / 0 - 20 °C
View Scheme
(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

(25R)-2α,3α-epoxy-5-hydroxy-5β-spirostan-6-one
876908-23-5

(25R)-2α,3α-epoxy-5-hydroxy-5β-spirostan-6-one

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 74 percent / KOH / methanol / 24 h / Heating
2: pyridine / 24 h / 20 °C
3: 2.36 g / Li2CO3; LiBr / dimethylformamide / 2 h / Heating
4: 24 percent / mCPBA / CH2Cl2 / 0 - 20 °C
View Scheme
(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

(25R)-3α,5-dihydroxy-5α-spirostan-6-one
876908-19-9

(25R)-3α,5-dihydroxy-5α-spirostan-6-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: Ph3P; DIAD / tetrahydrofuran / 24 h / 20 °C
2: 800 mg / NaHCO3 / methanol; H2O / 1 h / 20 °C
View Scheme
(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

(25R)-3α,5-dihydroxy-5β-spirostan-6-one

(25R)-3α,5-dihydroxy-5β-spirostan-6-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: Ph3P; DIAD / tetrahydrofuran / 24 h / 20 °C
2: 800 mg / NaHCO3 / methanol; H2O / 1 h / 20 °C
3: 71 percent / KOH / methanol / 24 h / Heating
View Scheme
(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

(25R)-3β-azido-5-hydroxy-5α-spirostan-6-one
876908-28-0

(25R)-3β-azido-5-hydroxy-5α-spirostan-6-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: Ph3P; DIAD / tetrahydrofuran / 24 h / 40 °C
2: 595 mg / NaN3 / various solvent(s) / 48 h / 50 °C
View Scheme
Multi-step reaction with 2 steps
1: dmap; di-isopropyl azodicarboxylate; triphenylphosphine / tetrahydrofuran / 48.25 h / 20 °C / Inert atmosphere
2: sodium azide / 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone / 48 h / 20 °C / Inert atmosphere
View Scheme
(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

(25R)-2β,3β,5-trihydroxy-5α-spirostan-6-one
705941-87-3

(25R)-2β,3β,5-trihydroxy-5α-spirostan-6-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: pyridine / 24 h / 20 °C
2.1: 2.29 g / LiBr; Li2CO3 / dimethylformamide / 2 h / Heating
3.1: AcOAg; I2 / acetic acid; H2O / 3 h / Heating
3.2: 61 percent / KOH / methanol / 0.5 h / Heating
View Scheme
(25R)-3β,5-dihydroxy-5α-spirostan-6-one
56786-63-1

(25R)-3β,5-dihydroxy-5α-spirostan-6-one

(25R)-2β,3β,5-trihydroxy-5β-spirostan-6-one
876908-22-4

(25R)-2β,3β,5-trihydroxy-5β-spirostan-6-one

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 74 percent / KOH / methanol / 24 h / Heating
2: pyridine / 24 h / 20 °C
3: 2.36 g / Li2CO3; LiBr / dimethylformamide / 2 h / Heating
4: 68 percent / NMO; OsO4 / tetrahydrofuran; 2-methyl-propan-2-ol; H2O / 24 h / 20 °C
View Scheme

56786-63-1Relevant articles and documents

Synthesis of new steroidal carbamates with plant-growth-promoting activity: Theoretical and experimental evidence

Pacheco, Daylin Fernández,Ceballos, Leonardo González,Castro, Armando Zaldo,Conde González, Marcos R.,de la Torre, Laura González,Rostgaard, Lia Pérez,Espinoza, Luis,Díaz, Katy,Olea, Andrés F.,García, Yamilet Coll

, p. 1 - 19 (2021/03/01)

A priority of modern agriculture is to use novel and environmentally friendly plant-growth promoter compounds to increase crop yields and avoid the indiscriminate use of synthetic fertilizers. Brassinosteroids are directly involved in the growth and development of plants and are considered attractive candidates to solve this problem. Obtaining these metabolites from their natural sources is expensive and cumbersome since they occur in extremely low concentrations in plants. For this reason, much effort has been dedicated in the last decades to synthesize brassino-steroids analogs. In this manuscript, we present the synthesis and characterization of seven steroi-dal carbamates starting from stigmasterol, β-sitosterol, diosgenin and several oxygenated derivatives of it. The synthesis route for functionalization of diosgenin included epoxidation and epoxy opening reactions, reduction of carbonyl groups, selective oxidation of hydroxyl groups, among others. All the obtained compounds were characterized by1H and13C NMR, HRMS, and their melting points are also reported. Rice lamina inclination test performed at different concentrations es-tablished that all reported steroidal carbamates show plant-growth-promoting activity. A molecular docking study evaluated the affinity of the synthesized compounds towards the BRI1-BAK1 receptor from Arabidopsis thaliana and three of the docked compounds displayed a binding energy lower than brassinolide.

In vitro neuroprotective and anti-inflammatory activities of natural and semi-synthetic spirosteroid analogues

García-Pupo, Laura,Zaldo-Castro, Armando,Exarchou, Vassiliki,Tacoronte-Morales, Juan Enrique,Pieters, Luc,Berghe, Wim Vanden,Nu?ez-Figueredo, Yanier,Delgado-Hernández, René

, (2016/08/12)

Two spirosteroid analogues were synthesized and evaluated for their in vitro neuroprotective activities in PC12 cells, against glutamate-induced excitotoxicity and mitochondrial damage in glucose deprivation conditions, as well as their anti-inflammatory potential in LPS/IFNγ-stimulated microglia primary cultures. We also evaluated the in vitro anti-excitotoxic and anti-inflammatory activities of natural and endogenous steroids. Our results show that the plant-derived steroid solasodine decreased PC12 glutamate-induced excitotoxicity, but not the cell death induced by mitochondrial damage and glucose deprivation. Among the two synthetic spirosteroid analogues, only the (25R)-5α-spirostan-3,6-one (S15) protected PC12 against ischemia-related in vitro models and inhibited NO production, as well as the release of IL-1β by stimulated primary microglia. These findings provide further insights into the role of specific modifications of the A and B rings of sapogenins for their neuroprotective potential.

Novel 5β-hydroxyspirostan-6-ones ecdysteroid antagonists: Synthesis and biological testing

Rivera, Daniel G.,León, Fredy,Coll, Francisco,Davison, Gema P.

, p. 1 - 11 (2007/10/03)

Eight new 5β-hydroxy-spirostan-6-ones bearing hydroxy and amino functions in the A ring, i.e., 3β-OH, 3α-OH, 2β,3β-OH, 2α,3β-OH, 3β-NH2, 2α-NH2-3β-OH, 2β-NH2-3β-OH, and 2β-OH-3β-NH2, were efficiently synthesized, and their antiecdysteroid activities were evaluated on the metamorphosis bioassay of mosquito Aedes aegypti. To our knowledge, these new steroids represent the first 5β-hydroxy-spirostanes which have been tested for antiecdysteroid activity in mosquitoes. The higher antagonistic effect was found for compounds bearing the 3β-hydroxy and 2β,3β-dihydroxy functionality, which show promise as environmental friendly insecticides.

The preparation of the spirostanic analogues of brassinolide and castasterone

Robaina Rodriguez, Caridad M.,Teixeira Zullo, Marco Antonio,Queiroz, Helena Mueller,Martins De Azevedo, Mariangela De Burgos,Becerra, Esther Alonso,Manchado, Francisco Coll

, p. 637 - 646 (2007/10/03)

Methods for the preparation of the spirostanic analogues of brassinosteroids (25R)-5α-spirostan-6-one-2α,3α-diol and (25R)-B-homo-5α-spirostan-6-oxo-7-oxalactone-2α,3α-diol, starting from diosgenin, were examined. The best preparative route was via diosgenin tosylation, isosteroidal rearrangement with potassium acetate in aqueous acetone, oxidation with Jones reagent, cyclopropyl ring opening with hydrobromic acid, hydrogen bromide elimination with lithium bromide and carbonate, dihydroxylation with osmium tetroxide and N-methylmorpholine N-oxide, producing (25R)-5α-spirostan-6-one-2α,3α-diol in 57.3% overall yield and lactonization with trifluoroperoxyacetic acid producing (25R)-B-homo-5α-spirostan-6-oxo-7-oxalactone-2α,3α-diol in 24.6% overall yield from diosgenin. The shortest route to (25R)-5α-spirostan-6-one-2α,3α-diol results in only 39.4% overall yield.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 56786-63-1